UniProt ID | ERCC5_HUMAN | |
---|---|---|
UniProt AC | P28715 | |
Protein Name | DNA repair protein complementing XP-G cells | |
Gene Name | ERCC5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1186 | |
Subcellular Localization | Nucleus . | |
Protein Description | Single-stranded structure-specific DNA endonuclease involved in DNA excision repair. Makes the 3'incision in DNA nucleotide excision repair (NER). Acts as a cofactor for a DNA glycosylase that removes oxidized pyrimidines from DNA. May also be involved in transcription-coupled repair of this kind of damage, in transcription by RNA polymerase II, and perhaps in other processes too.. | |
Protein Sequence | MGVQGLWKLLECSGRQVSPEALEGKILAVDISIWLNQALKGVRDRHGNSIENPHLLTLFHRLCKLLFFRIRPIFVFDGDAPLLKKQTLVKRRQRKDLASSDSRKTTEKLLKTFLKRQAIKTAFRSKRDEALPSLTQVRRENDLYVLPPLQEEEKHSSEEEDEKEWQERMNQKQALQEEFFHNPQAIDIESEDFSSLPPEVKHEILTDMKEFTKRRRTLFEAMPEESDDFSQYQLKGLLKKNYLNQHIEHVQKEMNQQHSGHIRRQYEDEGGFLKEVESRRVVSEDTSHYILIKGIQAKTVAEVDSESLPSSSKMHGMSFDVKSSPCEKLKTEKEPDATPPSPRTLLAMQAALLGSSSEEELESENRRQARGRNAPAAVDEGSISPRTLSAIKRALDDDEDVKVCAGDDVQTGGPGAEEMRINSSTENSDEGLKVRDGKGIPFTATLASSSVNSAEEHVASTNEGREPTDSVPKEQMSLVHVGTEAFPISDESMIKDRKDRLPLESAVVRHSDAPGLPNGRELTPASPTCTNSVSKNETHAEVLEQQNELCPYESKFDSSLLSSDDETKCKPNSASEVIGPVSLQETSSIVSVPSEAVDNVENVVSFNAKEHENFLETIQEQQTTESAGQDLISIPKAVEPMEIDSEESESDGSFIEVQSVISDEELQAEFPETSKPPSEQGEEELVGTREGEAPAESESLLRDNSERDDVDGEPQEAEKDAEDSLHEWQDINLEELETLESNLLAQQNSLKAQKQQQERIAATVTGQMFLESQELLRLFGIPYIQAPMEAEAQCAILDLTDQTSGTITDDSDIWLFGARHVYRNFFNKNKFVEYYQYVDFHNQLGLDRNKLINLAYLLGSDYTEGIPTVGCVTAMEILNEFPGHGLEPLLKFSEWWHEAQKNPKIRPNPHDTKVKKKLRTLQLTPGFPNPAVAEAYLKPVVDDSKGSFLWGKPDLDKIREFCQRYFGWNRTKTDESLFPVLKQLDAQQTQLRIDSFFRLAQQEKEDAKRIKSQRLNRAVTCMLRKEKEAAASEIEAVSVAMEKEFELLDKAKGKTQKRGITNTLEESSSLKRKRLSDSKGKNTCGGFLGETCLSESSDGSSSEDAESSSLMNVQRRTAAKEPKTSASDSQNSVKEAPVKNGGATTSSSSDSDDDGGKEKMVLVTARSVFGKKRRKLRRARGRKRKT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Acetylation | MGVQGLWKLLECSGR CCHHHHHHHHHCCCC | 48.51 | 19608861 | |
8 | Ubiquitination | MGVQGLWKLLECSGR CCHHHHHHHHHCCCC | 48.51 | 19608861 | |
64 | Acetylation | TLFHRLCKLLFFRIR HHHHHHHHHHHHHCC | 53.46 | 25953088 | |
64 | Ubiquitination | TLFHRLCKLLFFRIR HHHHHHHHHHHHHCC | 53.46 | 23000965 | |
85 | Ubiquitination | GDAPLLKKQTLVKRR CCCCHHHHHHHHHHH | 48.78 | - | |
99 | Phosphorylation | RQRKDLASSDSRKTT HHHHHHCCCCCHHHH | 41.81 | 20068231 | |
100 | Phosphorylation | QRKDLASSDSRKTTE HHHHHCCCCCHHHHH | 33.72 | 20068231 | |
102 | Phosphorylation | KDLASSDSRKTTEKL HHHCCCCCHHHHHHH | 37.31 | 20873877 | |
106 | Phosphorylation | SSDSRKTTEKLLKTF CCCCHHHHHHHHHHH | 33.87 | 30576142 | |
111 | Ubiquitination | KTTEKLLKTFLKRQA HHHHHHHHHHHHHHH | 47.90 | - | |
120 | Ubiquitination | FLKRQAIKTAFRSKR HHHHHHHHHHHHHHH | 36.49 | 29967540 | |
121 | Phosphorylation | LKRQAIKTAFRSKRD HHHHHHHHHHHHHHH | 25.56 | 21964256 | |
126 | Ubiquitination | IKTAFRSKRDEALPS HHHHHHHHHHHCCCC | 60.66 | 29967540 | |
133 | Phosphorylation | KRDEALPSLTQVRRE HHHHCCCCCCCCCCC | 44.92 | 28555341 | |
144 | Phosphorylation | VRRENDLYVLPPLQE CCCCCCEEEECCCCH | 11.64 | 22496350 | |
156 | Phosphorylation | LQEEEKHSSEEEDEK CCHHHCCCCHHHHHH | 50.98 | 23927012 | |
157 | Phosphorylation | QEEEKHSSEEEDEKE CHHHCCCCHHHHHHH | 49.07 | 25159151 | |
172 | Ubiquitination | WQERMNQKQALQEEF HHHHHHHHHHHHHHH | 32.31 | 29967540 | |
209 | Ubiquitination | HEILTDMKEFTKRRR HHHHHCHHHHHHHHH | 53.11 | 29967540 | |
213 | Ubiquitination | TDMKEFTKRRRTLFE HCHHHHHHHHHHHHH | 49.59 | - | |
217 | Phosphorylation | EFTKRRRTLFEAMPE HHHHHHHHHHHHCCC | 33.71 | 28122231 | |
235 | Ubiquitination | DFSQYQLKGLLKKNY CCHHHHHHHHHHHHH | 31.80 | 29967540 | |
240 | Ubiquitination | QLKGLLKKNYLNQHI HHHHHHHHHHHHHHH | 51.28 | 29967540 | |
252 | Ubiquitination | QHIEHVQKEMNQQHS HHHHHHHHHHHHHCC | 58.82 | 29967540 | |
274 | Ubiquitination | EDEGGFLKEVESRRV ECCCCCCHHHHHCEE | 58.41 | 29967540 | |
287 | O-linked_Glycosylation | RVVSEDTSHYILIKG EEECCCCCEEEEEEC | 26.98 | 30379171 | |
287 | Phosphorylation | RVVSEDTSHYILIKG EEECCCCCEEEEEEC | 26.98 | 25003641 | |
289 | Phosphorylation | VSEDTSHYILIKGIQ ECCCCCEEEEEECCE | 9.37 | 28796482 | |
293 | Ubiquitination | TSHYILIKGIQAKTV CCEEEEEECCEEEEE | 46.66 | 21890473 | |
293 (in isoform 1) | Ubiquitination | - | 46.66 | 21890473 | |
293 | Ubiquitination | TSHYILIKGIQAKTV CCEEEEEECCEEEEE | 46.66 | 21890473 | |
298 | Ubiquitination | LIKGIQAKTVAEVDS EEECCEEEEEEEECC | 27.44 | 29967540 | |
305 | Phosphorylation | KTVAEVDSESLPSSS EEEEEECCCCCCCCC | 33.97 | 27251275 | |
307 | Phosphorylation | VAEVDSESLPSSSKM EEEECCCCCCCCCHH | 49.92 | 21815630 | |
310 | O-linked_Glycosylation | VDSESLPSSSKMHGM ECCCCCCCCCHHCCC | 53.16 | 30379171 | |
310 | Phosphorylation | VDSESLPSSSKMHGM ECCCCCCCCCHHCCC | 53.16 | 21815630 | |
311 | Phosphorylation | DSESLPSSSKMHGMS CCCCCCCCCHHCCCC | 31.85 | 25159151 | |
312 | Phosphorylation | SESLPSSSKMHGMSF CCCCCCCCHHCCCCE | 38.03 | 21815630 | |
313 | Acetylation | ESLPSSSKMHGMSFD CCCCCCCHHCCCCEE | 36.54 | 25953088 | |
313 | Ubiquitination | ESLPSSSKMHGMSFD CCCCCCCHHCCCCEE | 36.54 | 29967540 | |
318 | Phosphorylation | SSKMHGMSFDVKSSP CCHHCCCCEECCCCH | 23.92 | 25159151 | |
322 | Ubiquitination | HGMSFDVKSSPCEKL CCCCEECCCCHHHHC | 47.24 | 29967540 | |
323 | Phosphorylation | GMSFDVKSSPCEKLK CCCEECCCCHHHHCC | 39.08 | 28450419 | |
324 | Phosphorylation | MSFDVKSSPCEKLKT CCEECCCCHHHHCCC | 28.05 | 27422710 | |
331 | Phosphorylation | SPCEKLKTEKEPDAT CHHHHCCCCCCCCCC | 63.83 | 23927012 | |
338 | Phosphorylation | TEKEPDATPPSPRTL CCCCCCCCCCCHHHH | 43.01 | 29255136 | |
341 | Phosphorylation | EPDATPPSPRTLLAM CCCCCCCCHHHHHHH | 28.37 | 29255136 | |
344 | Phosphorylation | ATPPSPRTLLAMQAA CCCCCHHHHHHHHHH | 29.52 | 26074081 | |
355 | Phosphorylation | MQAALLGSSSEEELE HHHHHHCCCCHHHHH | 30.57 | 21955146 | |
356 | Phosphorylation | QAALLGSSSEEELES HHHHHCCCCHHHHHH | 39.71 | 21955146 | |
357 | Phosphorylation | AALLGSSSEEELESE HHHHCCCCHHHHHHH | 51.21 | 21955146 | |
363 | Phosphorylation | SSEEELESENRRQAR CCHHHHHHHHHHHHC | 53.44 | 20363803 | |
382 | Phosphorylation | PAAVDEGSISPRTLS CCCCCCCCCCHHHHH | 20.18 | 29255136 | |
384 | Phosphorylation | AVDEGSISPRTLSAI CCCCCCCCHHHHHHH | 15.27 | 19664994 | |
387 | Phosphorylation | EGSISPRTLSAIKRA CCCCCHHHHHHHHHH | 28.57 | 26074081 | |
389 | Phosphorylation | SISPRTLSAIKRALD CCCHHHHHHHHHHCC | 27.60 | 25159151 | |
392 | Acetylation | PRTLSAIKRALDDDE HHHHHHHHHHCCCCC | 31.19 | 25953088 | |
392 | Ubiquitination | PRTLSAIKRALDDDE HHHHHHHHHHCCCCC | 31.19 | 29967540 | |
402 | Ubiquitination | LDDDEDVKVCAGDDV CCCCCCCEEECCCCC | 43.87 | 21963094 | |
423 | Phosphorylation | AEEMRINSSTENSDE CCEECCCCCCCCCCC | 35.94 | 25159151 | |
424 | Phosphorylation | EEMRINSSTENSDEG CEECCCCCCCCCCCC | 34.94 | 25159151 | |
425 | Phosphorylation | EMRINSSTENSDEGL EECCCCCCCCCCCCC | 38.72 | 21712546 | |
428 | Phosphorylation | INSSTENSDEGLKVR CCCCCCCCCCCCCCC | 30.70 | 25159151 | |
433 | Ubiquitination | ENSDEGLKVRDGKGI CCCCCCCCCCCCCCC | 46.19 | 33845483 | |
438 | Acetylation | GLKVRDGKGIPFTAT CCCCCCCCCCCCEEE | 58.94 | 25953088 | |
477 | Phosphorylation | SVPKEQMSLVHVGTE CCCHHHHCEEEECCC | 27.25 | 28555341 | |
489 | Phosphorylation | GTEAFPISDESMIKD CCCEECCCCHHHCCC | 35.25 | 28555341 | |
511 | Phosphorylation | ESAVVRHSDAPGLPN CHHEECCCCCCCCCC | 25.55 | 28555341 | |
523 | Phosphorylation | LPNGRELTPASPTCT CCCCCEECCCCCCCC | 16.44 | 30266825 | |
526 | Phosphorylation | GRELTPASPTCTNSV CCEECCCCCCCCCCC | 23.19 | 19664994 | |
528 | Phosphorylation | ELTPASPTCTNSVSK EECCCCCCCCCCCCC | 29.48 | 30266825 | |
530 | Phosphorylation | TPASPTCTNSVSKNE CCCCCCCCCCCCCCH | 32.76 | 30266825 | |
532 | Phosphorylation | ASPTCTNSVSKNETH CCCCCCCCCCCCHHH | 15.04 | 30278072 | |
534 | Phosphorylation | PTCTNSVSKNETHAE CCCCCCCCCCHHHHH | 29.59 | 23927012 | |
538 | Phosphorylation | NSVSKNETHAEVLEQ CCCCCCHHHHHHHHH | 35.46 | 22210691 | |
552 | Phosphorylation | QQNELCPYESKFDSS HHHCCCCCCCCCCHH | 31.66 | 27732954 | |
554 | Phosphorylation | NELCPYESKFDSSLL HCCCCCCCCCCHHHC | 32.55 | 26074081 | |
558 | Phosphorylation | PYESKFDSSLLSSDD CCCCCCCHHHCCCCC | 26.47 | 30266825 | |
559 | Phosphorylation | YESKFDSSLLSSDDE CCCCCCHHHCCCCCC | 34.86 | 30266825 | |
562 | Phosphorylation | KFDSSLLSSDDETKC CCCHHHCCCCCCCCC | 36.69 | 29255136 | |
563 | Phosphorylation | FDSSLLSSDDETKCK CCHHHCCCCCCCCCC | 49.39 | 29255136 | |
567 | Phosphorylation | LLSSDDETKCKPNSA HCCCCCCCCCCCCCH | 49.05 | 29255136 | |
573 | Phosphorylation | ETKCKPNSASEVIGP CCCCCCCCHHHCCCC | 41.52 | 26074081 | |
575 | Phosphorylation | KCKPNSASEVIGPVS CCCCCCHHHCCCCCC | 32.02 | 26074081 | |
605 | Phosphorylation | DNVENVVSFNAKEHE CCCCCEECCCHHHHH | 14.43 | 24719451 | |
662 | Phosphorylation | IEVQSVISDEELQAE EEEEEEECCHHHHHH | 36.49 | 22817901 | |
678 | Phosphorylation | PETSKPPSEQGEEEL CCCCCCCHHHCCCCC | 51.59 | 22817901 | |
697 | Phosphorylation | EGEAPAESESLLRDN CCCCCCCCHHHHCCC | 34.29 | 25850435 | |
699 | Phosphorylation | EAPAESESLLRDNSE CCCCCCHHHHCCCCC | 41.82 | 21815630 | |
705 | Phosphorylation | ESLLRDNSERDDVDG HHHHCCCCCCCCCCC | 37.99 | 30576142 | |
724 | Phosphorylation | AEKDAEDSLHEWQDI HHHHHHHHHHHHHCC | 24.11 | 25159151 | |
738 | Phosphorylation | INLEELETLESNLLA CCHHHHHHHHHHHHH | 48.74 | 20068231 | |
741 | Phosphorylation | EELETLESNLLAQQN HHHHHHHHHHHHHHH | 35.57 | 20068231 | |
749 | Phosphorylation | NLLAQQNSLKAQKQQ HHHHHHHHHHHHHHH | 27.23 | 20068231 | |
751 | Ubiquitination | LAQQNSLKAQKQQQE HHHHHHHHHHHHHHH | 48.90 | 29967540 | |
830 | Ubiquitination | RNFFNKNKFVEYYQY HHCCCCCCCEEEEEE | 53.01 | - | |
904 | Ubiquitination | HEAQKNPKIRPNPHD HHHHHCCCCCCCCCC | 61.82 | 29967540 | |
920 | Phosphorylation | KVKKKLRTLQLTPGF HHHHHHCCCCCCCCC | 29.32 | 20068231 | |
924 | Phosphorylation | KLRTLQLTPGFPNPA HHCCCCCCCCCCCHH | 14.38 | 20068231 | |
936 | Phosphorylation | NPAVAEAYLKPVVDD CHHHHHHHHCCEEEC | 13.53 | 20068231 | |
952 | Ubiquitination | KGSFLWGKPDLDKIR CCCCCCCCCCHHHHH | 24.63 | 29967540 | |
971 | Phosphorylation | RYFGWNRTKTDESLF HHHCCCCCCCCCHHH | 34.77 | 23403867 | |
972 | Ubiquitination | YFGWNRTKTDESLFP HHCCCCCCCCCHHHH | 51.22 | 29967540 | |
973 | Phosphorylation | FGWNRTKTDESLFPV HCCCCCCCCCHHHHH | 44.37 | 23403867 | |
976 | Phosphorylation | NRTKTDESLFPVLKQ CCCCCCCHHHHHHHH | 37.81 | 23403867 | |
982 | Ubiquitination | ESLFPVLKQLDAQQT CHHHHHHHHHCHHHH | 49.39 | 29967540 | |
995 | Phosphorylation | QTQLRIDSFFRLAQQ HHHHHHHHHHHHHHH | 24.74 | 24719451 | |
1004 | Ubiquitination | FRLAQQEKEDAKRIK HHHHHHHHHHHHHHH | 57.46 | 24816145 | |
1012 | Phosphorylation | EDAKRIKSQRLNRAV HHHHHHHHHHHHHHH | 20.40 | 24719451 | |
1020 | Phosphorylation | QRLNRAVTCMLRKEK HHHHHHHHHHHHHHH | 7.39 | 24719451 | |
1032 | Phosphorylation | KEKEAAASEIEAVSV HHHHHHHHHHHHHHH | 34.09 | 30576142 | |
1050 | Acetylation | KEFELLDKAKGKTQK HHHHHHHHHCCCCCC | 52.55 | 25953088 | |
1050 | Ubiquitination | KEFELLDKAKGKTQK HHHHHHHHHCCCCCC | 52.55 | - | |
1063 | Phosphorylation | QKRGITNTLEESSSL CCCCCCCHHHHCCHH | 27.22 | 28555341 | |
1067 | Phosphorylation | ITNTLEESSSLKRKR CCCHHHHCCHHCHHH | 18.82 | 23401153 | |
1068 | Phosphorylation | TNTLEESSSLKRKRL CCHHHHCCHHCHHHC | 42.86 | 30576142 | |
1069 | Phosphorylation | NTLEESSSLKRKRLS CHHHHCCHHCHHHCC | 47.38 | 25159151 | |
1071 | Methylation | LEESSSLKRKRLSDS HHHCCHHCHHHCCCC | 58.80 | 115978467 | |
1071 | Ubiquitination | LEESSSLKRKRLSDS HHHCCHHCHHHCCCC | 58.80 | - | |
1124 | Phosphorylation | TAAKEPKTSASDSQN HHCCCCCCCCCCCCC | 39.99 | 27794612 | |
1125 | Phosphorylation | AAKEPKTSASDSQNS HCCCCCCCCCCCCCC | 31.72 | 27794612 | |
1127 | Phosphorylation | KEPKTSASDSQNSVK CCCCCCCCCCCCCCC | 37.25 | 27794612 | |
1129 | Phosphorylation | PKTSASDSQNSVKEA CCCCCCCCCCCCCCC | 28.85 | 21712546 | |
1132 | Phosphorylation | SASDSQNSVKEAPVK CCCCCCCCCCCCCCC | 27.25 | 21712546 | |
1139 | Acetylation | SVKEAPVKNGGATTS CCCCCCCCCCCCCCC | 49.14 | 7711251 | |
1145 | Phosphorylation | VKNGGATTSSSSDSD CCCCCCCCCCCCCCC | 26.52 | - | |
1147 | Phosphorylation | NGGATTSSSSDSDDD CCCCCCCCCCCCCCC | 31.59 | - | |
1148 | Phosphorylation | GGATTSSSSDSDDDG CCCCCCCCCCCCCCC | 37.62 | - | |
1149 | Phosphorylation | GATTSSSSDSDDDGG CCCCCCCCCCCCCCC | 42.98 | - | |
1151 | Phosphorylation | TTSSSSDSDDDGGKE CCCCCCCCCCCCCCE | 44.91 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ERCC5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERCC5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCNA_HUMAN | PCNA | physical | 9305916 | |
ERCC2_HUMAN | ERCC2 | physical | 8652557 | |
EWS_HUMAN | EWSR1 | physical | 16713569 | |
RPB1_HUMAN | POLR2A | physical | 16246722 | |
ERCC6_HUMAN | ERCC6 | physical | 16246722 | |
DTL_HUMAN | DTL | physical | 25483071 | |
BRCA2_HUMAN | BRCA2 | physical | 26833090 | |
PALB2_HUMAN | PALB2 | physical | 26833090 | |
RAD51_HUMAN | RAD51 | physical | 26833090 | |
BRCA1_HUMAN | BRCA1 | physical | 26833090 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
278780 | Xeroderma pigmentosum complementation group G (XP-G) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384; SER-559; SER-562AND SER-563, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384; SER-526; SER-562AND SER-563, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-157; THR-338;SER-341; SER-355; SER-356; SER-357; SER-382; SER-384; SER-423;SER-424; SER-428; SER-559; SER-562 AND SER-563, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384 AND SER-526, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-384 AND SER-526, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156; SER-157; SER-355;SER-356; SER-357; SER-384 AND SER-724, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-338; SER-341; SER-355;SER-356; SER-357; SER-384; SER-428; SER-526 AND SER-563, AND MASSSPECTROMETRY. |